PharmaCyte Biotech (PMCB) Treasury Stock (2014 - 2026)
PharmaCyte Biotech's Treasury Shares was $45.01 million in fiscal Q1 2027 (quarter ended Jul 31, 2026), up 0.9% from $44.61 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
PharmaCyte Biotech (PMCB) Treasury Stock (2014 - 2026) Analysis & Trends
From fiscal Q1 2023 onward, PharmaCyte Biotech has reported Treasury Shares for 17 quarters.
- Treasury Shares has now increased for three consecutive fiscal years, with a three-year compound annual growth rate of 49.2% (FY2023 to FY2026).
- In earlier fiscal years, Treasury Shares was $44.61 million in FY2025 (+6.1%), $42.04 million in FY2024 (+210.0%) and $13.56 million in FY2023.
- Compared with a year earlier, Treasury Shares has increased for 12 straight quarters, with growth averaging 4.1% over the last eight quarters.
- The year-over-year growth in Treasury Shares has ranged between 0.9% (fiscal Q4 2026) and 638.7% (fiscal Q2 2024) over the last five years.
- Per Business Quant data, PMCB's Treasury Shares in the three fiscal quarters before Q1 2027 was $45.01 million (Q4 2026), $45.01 million (Q3 2026) and $44.61 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Stock (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -3.01 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 76.18 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 10.62 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 64.59 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 115.20 Bn |
| 10 | PharmaCyte Biotech | 4.29 Mn | -68.55 Mn | - | 45.01 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 45.01 Mn |
| Apr 30, 2026 | 45.01 Mn |
| Jan 31, 2026 | 45.01 Mn |
| Oct 31, 2025 | 44.61 Mn |
| Jul 31, 2025 | 44.61 Mn |
| Apr 30, 2025 | 44.61 Mn |
| Jan 31, 2025 | 44.43 Mn |
| Oct 31, 2024 | 44.21 Mn |
| Jul 31, 2024 | 42.79 Mn |
| Apr 30, 2024 | 42.04 Mn |
| Jan 31, 2024 | 40.85 Mn |
| Oct 31, 2023 | 40.45 Mn |
| Jul 31, 2023 | 40.02 Mn |
| Apr 30, 2023 | 13.56 Mn |
| Jan 31, 2023 | 9.25 Mn |
| Oct 31, 2022 | 5.48 Mn |
| Jul 31, 2022 | 2.09 Mn |
| Jan 31, 2014 | -50,000.00 |
API Access
PharmaCyte Biotech Treasury Stock API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=treasury-shares&ticker=PMCB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "treasury-shares", "ticker": "PMCB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=treasury-shares&ticker=PMCB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();